Klebsiella pneumoniae carbapenemase variants: the new threat to global public health

L Ding, S Shen, J Chen, Z Tian, Q Shi… - Clinical Microbiology …, 2023 - Am Soc Microbiol
Klebsiella pneumoniae carbapenemase (KPC) variants, which refer to the substitution,
insertion, or deletion of amino acid sequence compared to wild bla KPC type, have reduced …

Bacterial resistance to antibacterial agents: Mechanisms, control strategies, and implications for global health

T Li, Z Wang, J Guo, C de la Fuente-Nunez… - Science of The Total …, 2023 - Elsevier
The spread of bacterial drug resistance has posed a severe threat to public health globally.
Here, we cover bacterial resistance to current antibacterial drugs, including traditional herbal …

Global epidemiology and clinical outcomes of carbapenem-resistant Pseudomonas aeruginosa and associated carbapenemases (POP): a prospective cohort study

J Reyes, L Komarow, L Chen, L Ge, BM Hanson… - The Lancet …, 2023 - thelancet.com
Summary Background Carbapenem-resistant Pseudomonas aeruginosa (CRPA) is a global
threat, but the distribution and clinical significance of carbapenemases are unclear. The aim …

[HTML][HTML] Genomic epidemiology of global carbapenemase-producing Escherichia coli, 2015–2017

G Peirano, L Chen, D Nobrega, TJ Finn… - Emerging Infectious …, 2022 - ncbi.nlm.nih.gov
We describe the global molecular epidemiology of 229 carbapenemase-producing
Escherichia coli in 36 countries during 2015–2017. Common carbapenemases were …

A point mutation in recC associated with subclonal replacement of carbapenem-resistant Klebsiella pneumoniae ST11 in China

K Zhou, CX Xue, T Xu, P Shen, S Wei, KL Wyres… - Nature …, 2023 - nature.com
Adaptation to selective pressures is crucial for clinically important pathogens to establish
epidemics, but the underlying evolutionary drivers remain poorly understood. The current …

[HTML][HTML] Risk factors for infections caused by carbapenem-resistant Enterobacterales: an international matched case-control-control study (EURECA)

S Pérez-Galera, JM Bravo-Ferrer, M Paniagua… - …, 2023 - thelancet.com
Background Data on risk factors for carbapenem-resistant Enterobacterales (CRE) with
wider applicability are needed to inform preventive measures and efficient design of …

Cefiderocol, a siderophore cephalosporin, as a treatment option for infections caused by carbapenem-resistant Enterobacterales

KS Kaye, T Naas, JM Pogue, GM Rossolini - Infectious Diseases and …, 2023 - Springer
Carbapenem-resistant Enterobacterales (CRE) remain a significant public health threat,
and, despite recent approvals, new antibiotics are needed. Severe infections caused by …

Clinical Outcomes and Bacterial Characteristics of Carbapenem-resistant Acinetobacter baumannii Among Patients From Different Global Regions

M Wang, L Ge, L Chen, L Komarow… - Clinical Infectious …, 2024 - academic.oup.com
Abstract Background Carbapenem-resistant Acinetobacter baumannii (CRAb) is 1 of the
most problematic antimicrobial-resistant bacteria. We sought to elucidate the international …

ESKAPE pathogens: antimicrobial resistance, epidemiology, clinical impact and therapeutics

WR Miller, CA Arias - Nature Reviews Microbiology, 2024 - nature.com
The rise of antibiotic resistance and a dwindling antimicrobial pipeline have been
recognized as emerging threats to public health. The ESKAPE pathogens—Enterococcus …

Novel antimicrobial agents for gram-negative pathogens

M Karvouniaris, MP Almyroudi, MH Abdul-Aziz, S Blot… - Antibiotics, 2023 - mdpi.com
Gram-negative bacterial resistance to antimicrobials has had an exponential increase at a
global level during the last decades and represent an everyday challenge, especially for the …